Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 9623 

2021, HHS expanded their Overdose 

Prevention Strategy to focus on four 

strategic priorities: Primary prevention, 

harm reduction, evidence-based 

treatment, and recovery support. 

DOSE is a critical element of HHS’s 

first goal under primary prevention to 

support research and surveillance to 

collect timelier and more specific data 

through accelerating the speed at which 

CDC reports drug overdose data. DOSE 

data collection integrates, expands, and 

enhances previous data sharing efforts 

with public health departments initiated 

under ESOOS. The goal of DOSE is to 

conduct surveillance of approximately 

75% of all ED visits for drug overdoses 

through the end of the Overdose Data to 

Action (OD2A) cooperative agreement 

in 2023. In 2019, OD2A provided 

funding for 66 jurisdictions; 47 states 

and the District of Columbia share data 

with DOSE. Though we had hoped to 

capture data from all 50 states and the 

District of Columbia, only 47 states and 

the District of Columbia applied for this 

funding announcement. 

Currently, DOSE operates in the 47 

states and the District of Columbia 

currently funded by OD2A (three states 

did not request CDC funding in the 

current cycle but may for the next 

funding cycle in 2023). Of these 48 

health departments, 43 share syndromic 

data with CDC monthly and 26 share at 

least quarterly discharge data. A total of 

33 health departments provide CDC 

with access to their syndromic 

surveillance data from EDs in CDC’s 

National Syndromic Surveillance 

Program (NSSP) system. Access to this 

timely data has allowed us to improve 

the situational awareness of federal, 

state, and local health departments 

about emerging drug overdose outbreaks 

and the progression of the opioid 

overdose epidemic. Health departments 

have used this data to populate state 

data dashboards and develop alerts for 

local communities. In addition, health 

departments have used this data in 

concert with public safety partners to 

gain a better overall picture of outbreaks 

in their communities. 

All data sharing between CDC and 

health departments in DOSE is driven 

by two standardized data forms, the 

Rapid ED overdose data form and the 

ED discharge overdose data form, and 

CDC cases definitions of drug, opioid, 

heroin, fentanyl, all stimulant, cocaine, 

methamphetamine, benzodiazepine, and 

other emerging drug overdoses. The 

Rapid ED Overdose Data Form will be 

submitted to CDC monthly. For 35 

respondents, the estimated burden per 

response is 30 minutes. For 10 

respondents, the estimated burden per 

response is three hours. The estimated 

burden per response for the ED 

Discharge Overdose Data Form is three 

hours. This form will be submitted four 

times per year by 28 respondents and 

once per year by 23 respondents. All 

information will be collected 

electronically. The total estimated 

annualized burden hours are 975. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Participating health departments sharing aggregate data 

from local syndromic or hospital discharge file.

Rapid ED overdose data form 10 12 3 

Participating health departments sharing case-level ED data 

with CDC through the NSSP BioSense (OMB No. 0920– 

0824).

Rapid ED overdose data form 35 12 30/60 

Participating health department sharing finalized hospital discharge data on a quarterly basis.ED discharge overdose data 

form.

28 4 3 

Participating health department sharing finalized hospital discharge data on a yearly basis.ED discharge overdose data 

form.

23 1 3 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2022–03709 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Award of a Single-Source 

Cooperative Agreement To Fund the 

Ho Chi Minh City Department of Health 

(HCMC DOH), Vietnam 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), located 

within the Department of Health and 

Human Services (HHS), announces the 

award of approximately $2,000,000 for 

Year 1 of funding to the Ho Chi Minh 

City Department of Health (HCMC 

DOH). The award will strengthen the 

capacity of the HCMC DOH to provide 

sustainable evidence-based effective 

HIV prevention, care and treatment 

services. As Ho Chi Minh City 

contributes to 22.6% of the HIV burden, 

HCMC DOH remains critical to the 

success of HIV program in Vietnam. 

This NOFO will contribute directly to 

the national HIV prevention, care and 

treatment goals by supporting direct 

services and will support long-term 

sustainability of the HIV response 

through capacity building and technical 

assistance (TA). Funding amounts for 

years 2–5 will be set at continuation. 

DATES: The period for this award will be 

September 30, 2022 through September 

29, 2027. 

FOR FURTHER INFORMATION CONTACT: 

Amy Bailey, Center for Global Health, 

Centers for Disease Control and 

Prevention, 4 Le Duan, District 1, Ho 

Chi Minh City, Vietnam, Telephone: 

800–232–6348, E-Mail: fue8@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

single-source award will strengthen the 

capacity of the HCMC DOH to provide 

sustainable, evidence-based, effective 

HIV/AIDS prevention, care and 

treatment services. 

HCMC DOH is in a unique position to 

conduct this work as it is mandated to 

advise and assist the City People’s 

Committee in state management of 

health and in terms of legal authority 

and credibility among Vietnamese 

health institutions, to give direction, 

guide, coordinate and implement all 

public health including HIV/AIDS 

activities in HCMC. As Ho Chi Minh 

City (HCMC) contributes to 22.6% of the 

HIV burden, HCMC DOH remains 

critical to the success of HIV program in 


lotter on DSK11XQN23PROD with NOTICES1
9624 Federal Register / Vol. 87, No. 35 / Tuesday, February 22, 2022 / Notices 

Vietnam. This NOFO will contribute 

directly to the national HIV prevention, 

care, and treatment goals by supporting 

direct services and will support longterm sustainability of the HIV response 

through capacity building and TA. 

Summary of the Award 

Recipient: Ho Chi Minh City 

Department of Health (HCMC DOH). 

Purpose of the Award: The purpose of 

this award is to strengthen the capacity 

of the HCMC DOH to provide 

sustainable evidence-based effective 

HIV prevention, care and treatment 

services. 

Amount of Award: The approximate 

year 1 funding amount will be 

$2,000,000 in Federal Fiscal Year (FFY) 

2022 funds, subject to the availability of 

funds. Funding amounts for years 2–5 

will be set at continuation. 

Authority: This program is authorized 

under Public Law 108–25 (the United 

States Leadership Against HIV AIDS, 

Tuberculosis and Malaria Act of 2003). 

Period of Performance: September 30, 

2022 through September 29, 2027. 

Dated: February 15, 2022. 

Terrance Perry, 

Chief Grants Management Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. 2022–03628 Filed 2–18–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-22–22CR; Docket No. CDC–2022– 

0026] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing effort to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other federal 

agencies the opportunity to comment on 

a proposed and/or continuing 

information collection, as required by 

the Paperwork Reduction Act of 1995. 

This notice invites comment on a 

proposed information collection project 

titled Homeless Service Providers 

Knowledge, Attitudes, and Practices 

Regarding Body Lice, Fleas and 

Associated Diseases. This proposed 

study is designed to improve CDC’s 

understanding of homeless service 

providers knowledge, attitudes, and 

practices regarding vector-borne 

diseases that can affect persons 

experiencing homelessness. 

DATES: CDC must receive written 

comments on or before April 25, 2022. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2022– 

0026, by either of the following 

methods: 

• Federal eRulemaking Portal: 

regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–8, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. CDC will post, without 

change, all relevant comments to 

regulations.gov. 

PLEASE NOTE: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Jeffrey M. Zirger, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE, MS 

H21–8, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. In addition, the PRA also 

requires federal agencies to provide a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each new 

proposed collection, each proposed 

extension of existing collection of 

information, and each reinstatement of 

previously approved information 

collection before submitting the 

collection to the OMB for approval. To 

comply with this requirement, we are 

publishing this notice of a proposed 

data collection as described below. 

The OMB is particularly interested in 

comments that will help: 

1. Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

2. Evaluate the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

3. Enhance the quality, utility, and 

clarity of the information to be 

collected; 

4. Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submissions 

of responses; and 

5. Assess information collection costs. 

Proposed Project 

Homeless Service Providers 

Knowledge, Attitudes, and Practices 

Regarding Body Lice, Fleas and 

Associated Diseases—New—National 

Center for Emerging and Zoonotic 

Infectious Diseases (NCEZID), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

This proposed information collection 

aims to improve CDC’s understanding of 

homeless service providers knowledge, 

attitudes, and practices regarding 

vector-borne diseases that can affect 

persons experiencing homelessness 

(PEH). Insights gained from this 

information collection will be used to 

develop guidance for control of vectorborne diseases among PEH and to 

improve educational outreach regarding 

these diseases. 

Several bacterial vector-borne 

diseases that are spread by body lice 

and fleas disproportionately affect PEH. 

Given the potential severity of louseand flea-borne diseases, as well as their 

disproportionate impact on PEH, 

understanding the knowledge and gaps 

in knowledge of urban homeless service 

providers will allow for targeted 

education and interventions to reduce 

the risk of louse- and flea-borne disease 

among this vulnerable population. This 

investigation aims to gain insight about 

gaps in understanding, prevention, and 

intervention to inform tailored 

educational campaigns and intervention 

efforts to reduce risk of infestation with 

body lice and fleas and their associated 

diseases. 

CDC requests OMB approval for an 

estimated 38 annual burden hours. 

There is no cost to respondents other 

than their time. 


lotter on DSK11XQN23PROD with NOTICES1